selected scholarly activity
-
chapters
-
conferences
- Comparing characteristics and outcomes of cancer to non-cancer patients admitted to general internal medicine (GIM).. Journal of Clinical Oncology. 2020
- Comparison of prognostic models for hepatocellular carcinoma (HCC) in patients treated with the sorafenib: Results from a Canadian multi-center HCC database.. Journal of Clinical Oncology. e15653-e15653. 2017
- Risk and predictors of suicide in colorectal cancer patients: A SEER analysis. Journal of Clinical Oncology. 2013
-
journal articles
- The impact of admitting ward on resource utilization and outcomes among hospitalized cancer survivors.. Journal of Clinical Oncology. 20:36-36. 2024
- Comparing the characteristics and outcomes of hospitalizations between cancer and non-cancer survivors.. Journal of Clinical Oncology. 42:12138-12138. 2024
- The impact of admitting ward on resource utilization and outcomes among hospitalized cancer survivors.. Journal of Clinical Oncology. 42:1550-1550. 2024
- Evaluation of Adjuvant Chemotherapy-Associated Steatosis (CAS) in Colorectal Cancer. Current Oncology. 28:3030-3040. 2021
- Comparing characteristics and outcomes of cancer to non-cancer patients admitted to general internal medicine (GIM).. Journal of Clinical Oncology. 38:21-21. 2020
- Second‐line treatment of hepatocellular carcinoma after sorafenib: Characterizing treatments used over the past 10 years and real‐world eligibility for cabozantinib, regorafenib, and ramucirumab. Cancer Medicine. 9:4640-4647. 2020
- Progression-Free but No Overall Survival Benefit for Adult Patients with Bevacizumab Therapy for the Treatment of Newly Diagnosed Glioblastoma: A Systematic Review and Meta-Analysis. Cancers. 11:1723-1723. 2019
- Real-World Use of Trifluridine/Tipiracil for Patients with Metastatic Colorectal Cancer in Canada. Current Oncology. 26:319-329. 2019
- Updates in the management of intradural spinal cord tumors: a radiation oncology focus. Neuro-Oncology. 21:707-718. 2019
- Real world eligibility for cabozantinib (C), regorafenib (Reg), and ramucirumab (Ram) in hepatocellular carcinoma (HCC) patients after sorafenib (S).. Journal of Clinical Oncology. 37:422-422. 2019
- Treatment of hepatocellular carcinoma (HCC) after sorafenib (S) over the last 10 years.. Journal of Clinical Oncology. 37:438-438. 2019
- Effectiveness and components of self-management interventions in adult cancer survivors: a protocol for a systematic review and planned meta-analysis. Systematic Reviews. 7:238. 2018
- Primary Care Versus Oncology-Based Surveillance Following Adjuvant Chemotherapy in Resected Pancreatic Cancer. Journal of Gastrointestinal Cancer. 49:429-436. 2018
- Sex Disparities in Outcomes of Early Stage Colorectal Cancer: A Population-Based Study. Clinical Colorectal Cancer. 17:e711-e717. 2018
- Relationship between ethnicity and overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S): Results from a Canadian multi-centre HCC database. Annals of Oncology. 29:viii238-viii238. 2018
- Prognosis of patients with hepatocellular carcinoma treated with sorafenib: a comparison of five models in a large Canadian database. Cancer Medicine. 7:2816-2825. 2018
- A real-world comparison of multi-modality therapies in locally advanced gastro-esophageal junction (GEJ) cancers.. Journal of Clinical Oncology. 36:96-96. 2018
- Adjuvant therapy use and outcomes of stage II and III colorectal cancer (CRC): Comparison of young and elderly patients (pts) in a large, contemporary, population-based Canadian database.. Journal of Clinical Oncology. 36:807-807. 2018
- Relationship between ethnicity and overall survival (OS) in patients with advanced hepatocellular carcinoma (HCC) treated with sorafenib (S).. Journal of Clinical Oncology. 36:248-248. 2018
- Risk and Predictors of Suicide in Colorectal Cancer Patients: A Surveillance, Epidemiology, and End Results Analysis. Current Oncology. 24:513-517. 2017
- Comparison of prognostic models for hepatocellular carcinoma (HCC) in patients treated with the sorafenib: Results from a Canadian multi-center HCC database. Annals of Oncology. 28:v238-v238. 2017
- Development of a web-based application using machine learning algorithms to facilitate systematic literature reviews. Annals of Oncology. 28:v518-v518. 2017
- Effect of sorafenib (S) starting dose and dose intensity on survival in patients with hepatocellular carcinoma (HCC): Results from a Canadian multicenter HCC database.. Journal of Clinical Oncology. 35:4084-4084. 2017
- Patterns of unavoidable and potentially avoidable hospitalizations among cancer patients.. Journal of Clinical Oncology. 35:e18030-e18030. 2017
- Primary care vs. oncology-driven surveillance following adjuvant chemotherapy in resected pancreas cancer.. Journal of Clinical Oncology. 35:e18163-e18163. 2017
- Primary care vs. oncology-driven surveillance following adjuvant chemotherapy in resected pancreas cancer.. Journal of Clinical Oncology. 35:421-421. 2017
- The use of prognostic factors in metastatic renal cell carcinoma. Urologic Oncology: Seminars and Original Investigations. 33:509-516. 2015
- Risk and predictors of suicide in colorectal cancer patients: A SEER analysis.. Journal of Clinical Oncology. 31:9596-9596. 2013